Literature DB >> 28576406

Puerarin promotes ABCA1-mediated cholesterol efflux and decreases cellular lipid accumulation in THP-1 macrophages.

Cong-Hui Li1, Duo Gong2, Ling-Yan Chen2, Min Zhang2, Xiao-Dan Xia2, Hai-Peng Cheng2, Chong Huang2, Zhen-Wang Zhao2, Xi-Long Zheng3, Xiao-Er Tang4, Chao-Ke Tang5.   

Abstract

It was reported that puerarin decreases the total cholesterol, low-density lipoprotein cholesterol (LDL-C), triglyceride (TG) and increases high-density lipoprotein cholesterol (HDL-C) level, but the underlying mechanism is unclear. This study was designed to determine whether puerarin decreased lipid accumulation via up-regulation of ABCA1-mediated cholesterol efflux in THP-1 macrophage-derived foam cells. Our results showed that puerarin significantly promoted the expression of ATP-binding cassette transporter A1 (ABCA1) mRNA and protein via the AMP-activated protein kinase (AMPK)-peroxisome proliferator-activated receptor gamma (PPARγ)-liver X receptor-alpha (LXR-α) pathway and decreased cellular lipid accumulation in human THP-1 macrophage-derived foam cells. The miR-7 directly targeted 3' untranslated region of STK11 (Serine/Threonine Kinase 11), which activated the AMPK pathway. Transfection with miR-7 mimic significantly reduced STK11 expression in puerarin-treated macrophages, decreased the phosphorylation of AMPK, down-regulated the expression of the PPARγ-LXR-α-ABCA1 expression. Additionally, treatment with miR-7 decreased cholesterol efflux and increased cholesterol levels in THP-1 macrophage-derived foam cells. Our study demonstrates that puerarin promotes ABCA1-mediated cholesterol efflux and decreases intracellular cholesterol levels through the pathway involving miR-7, STK11, and the AMPK-PPARγ-LXR-α-ABCA1 cascade.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ABCA1; Cholesterol efflux; Lipid accumulation; Puerarin

Mesh:

Substances:

Year:  2017        PMID: 28576406     DOI: 10.1016/j.ejphar.2017.05.055

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  13 in total

Review 1.  Bioactive components to inhibit foam cell formation in atherosclerosis.

Authors:  Sanjiv Singh; Senti Changkija; Rajat Mudgal; V Ravichandiran
Journal:  Mol Biol Rep       Date:  2022-01-11       Impact factor: 2.316

Review 2.  Potential Therapeutic Agents That Target ATP Binding Cassette A1 (ABCA1) Gene Expression.

Authors:  Michael J Haas; Arshag D Mooradian
Journal:  Drugs       Date:  2022-07-21       Impact factor: 11.431

Review 3.  Molecular mechanisms for ABCA1-mediated cholesterol efflux.

Authors:  Lei Chen; Zhen-Wang Zhao; Peng-Hui Zeng; Ying-Jie Zhou; Wen-Jun Yin
Journal:  Cell Cycle       Date:  2022-02-22       Impact factor: 5.173

Review 4.  Role of microRNA-7 in liver diseases: a comprehensive review of the mechanisms and therapeutic applications.

Authors:  Sen Han; Ting Zhang; Praveen Kusumanchi; Nazmul Huda; Yanchao Jiang; Suthat Liangpunsakul; Zhihong Yang
Journal:  J Investig Med       Date:  2020-08-24       Impact factor: 3.235

5.  Dysregulation of cardiac lipid parameters in high-fat high-cholesterol diet-induced rat model.

Authors:  Qian Han; Sze C Yeung; Mary S M Ip; Judith C W Mak
Journal:  Lipids Health Dis       Date:  2018-11-14       Impact factor: 3.876

6.  The Forty-Sixth Euro Congress on Drug Synthesis and Analysis: Snapshot .

Authors:  Pavel Mucaji; Atanas G Atanasov; Andrzej Bak; Violetta Kozik; Karolina Sieron; Mark Olsen; Weidong Pan; Yazhou Liu; Shengchao Hu; Junjie Lan; Norbert Haider; Robert Musiol; Jan Vanco; Marc Diederich; Seungwon Ji; Jan Zitko; Dongdong Wang; Danica Agbaba; Katarina Nikolic; Slavica Oljacic; Jelica Vucicevic; Daniela Jezova; Anna Tsantili-Kakoulidou; Fotios Tsopelas; Constantinos Giaginis; Teresa Kowalska; Mieczyslaw Sajewicz; Jerzy Silberring; Przemyslaw Mielczarek; Marek Smoluch; Izabela Jendrzejewska; Jaroslaw Polanski; Josef Jampilek
Journal:  Molecules       Date:  2017-10-28       Impact factor: 4.411

7.  High Glucose Aggravates Cholesterol Accumulation in Glomerular Endothelial Cells Through the LXRs/LncRNAOR13C9/ABCA1 Regulatory Network.

Authors:  Yao Wang; Shumin Xiao; Saijun Zhou; Rui Zhang; Hongyan Liu; Yao Lin; Pei Yu
Journal:  Front Physiol       Date:  2020-10-19       Impact factor: 4.566

8.  Shen-Hong-Tong-Luo Formula Attenuates Macrophage Inflammation and Lipid Accumulation through the Activation of the PPAR-γ/LXR-α/ABCA1 Pathway.

Authors:  Zepeng Zhang; Lu Zhai; Jing Lu; Sanmiao Sun; Dandan Wang; Daqing Zhao; Liwei Sun; Weimin Zhao; Xiangyan Li; Ying Chen
Journal:  Oxid Med Cell Longev       Date:  2020-10-01       Impact factor: 6.543

Review 9.  Recent Molecular Mechanisms and Beneficial Effects of Phytochemicals and Plant-Based Whole Foods in Reducing LDL-C and Preventing Cardiovascular Disease.

Authors:  Salman Ul Islam; Muhammad Bilal Ahmed; Haseeb Ahsan; Young-Sup Lee
Journal:  Antioxidants (Basel)       Date:  2021-05-15

10.  Canagliflozin Facilitates Reverse Cholesterol Transport Through Activation of AMPK/ABC Transporter Pathway.

Authors:  Yingnan Zhao; Yanping Li; Qinhui Liu; Qin Tang; Zijing Zhang; Jinhang Zhang; Cuiyuan Huang; Hui Huang; Guorong Zhang; Jian Zhou; Jiamin Yan; Yan Xia; Zhiyong Zhang; Jinhan He
Journal:  Drug Des Devel Ther       Date:  2021-05-18       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.